Rafael de La Torre Fornell

Rafael de La Torre Fornell

Universidad Pompeu Fabra

H-index: 93

Europe-Spain

About Rafael de La Torre Fornell

Rafael de La Torre Fornell, With an exceptional h-index of 93 and a recent h-index of 56 (since 2020), a distinguished researcher at Universidad Pompeu Fabra, specializes in the field of Farmacología, Toxicología y Neurociencias.

His recent articles reflect a diverse array of research interests and contributions to the field:

Risk of cognitive decline progression is associated to increased blood‐brain‐barrier permeability: A longitudinal study in a memory unit clinical cohort

Protective effect of hydroxytyrosol and tyrosol metabolites in LPS-induced vascular barrier derangement in vitro

Hydroxytyrosol Linoleoyl Ether Ameliorates Metabolic-Associated Fatty Liver Disease Symptoms in Obese Zucker Rats

Low TGF-β1 plasma levels are associated with cognitive decline in Down syndrome

Diet patterns associated with cognitive decline: methods to harmonize data from European and US cohort studies

Role of cyclin-dependent kinase 5 in psychosis and the modulatory effects of cannabinoids

PPAR-γ is a promising therapeutic target for memory deficits induced by early alcohol exposure

Role for BDNF and Oleoylethanolamide (OEA) in cognitive impairment associated with alcohol use disorders in humans and preclinical models

Rafael de La Torre Fornell Information

University

Position

Director del Instituto del Hospital del Mar de Investigaciones (IMIM) Profesor de Toxicología Asociado a la

Citations(all)

33772

Citations(since 2020)

13517

Cited By

27183

hIndex(all)

93

hIndex(since 2020)

56

i10Index(all)

374

i10Index(since 2020)

265

Email

University Profile Page

Universidad Pompeu Fabra

Google Scholar

View Google Scholar Profile

Rafael de La Torre Fornell Skills & Research Interests

Farmacología

Toxicología y Neurociencias

Top articles of Rafael de La Torre Fornell

Title

Journal

Author(s)

Publication Date

Risk of cognitive decline progression is associated to increased blood‐brain‐barrier permeability: A longitudinal study in a memory unit clinical cohort

Alzheimer's & Dementia

Albert Puig‐Pijoan

Joan Jimenez‐Balado

Aida Fernández‐Lebrero

Greta García‐Escobar

Irene Navalpotro‐Gómez

...

2024/1

Protective effect of hydroxytyrosol and tyrosol metabolites in LPS-induced vascular barrier derangement in vitro

Frontiers in Nutrition

Sonia Zodio

Gabriele Serreli

Maria Paola Melis

Benedetta Franchi

Anna Boronat

...

2024/4/19

Hydroxytyrosol Linoleoyl Ether Ameliorates Metabolic-Associated Fatty Liver Disease Symptoms in Obese Zucker Rats

ACS Pharmacology & Translational Science

Rubén Tovar

Marialuisa de Ceglia

Miguel Rodríguez-Pozo

Antonio Vargas

Ana Gavito

...

2024/4/4

Low TGF-β1 plasma levels are associated with cognitive decline in Down syndrome

Frontiers in Pharmacology

Margherita Grasso

Annamaria Fidilio

Francesca L’Episcopo

Marilena Recupero

Concetta Barone

...

2024/3/21

Diet patterns associated with cognitive decline: methods to harmonize data from European and US cohort studies

Amaia Ayala-Garcia

Natalia Soldevila-Domenech

So-Yun Yi

Rafael de la Torre

Lyn M Steffen

...

2024/3/21

Role of cyclin-dependent kinase 5 in psychosis and the modulatory effects of cannabinoids

Neurobiology of Disease

Marta Barrera-Conde

Emma Veza-Estévez

Maria Gomis-Gonzalez

Jordi Garcia-Quintana

Amira Trabsa

...

2023/1/1

PPAR-γ is a promising therapeutic target for memory deficits induced by early alcohol exposure

bioRxiv

Alba Garcia-Baos

Antoni Pastor

Ines Gallego-Landin

Rafael de la Torre

Ferran Sanz

...

2023/1/21

Role for BDNF and Oleoylethanolamide (OEA) in cognitive impairment associated with alcohol use disorders in humans and preclinical models

Alcohol

Nerea Requena

Daniel Silva-Peña

Nuria García-Marchena

Maria Flores

Gabriel Rubio

...

2023/6/1

Olive Oil Phenolic Compounds’ Activity against Age-Associated Cognitive Decline: Clinical and Experimental Evidence

Anna Boronat

Gabriele Serreli

Jose Rodríguez-Morató

Monica Deiana

Rafael De la Torre

2023/7/22

Validity of REFRESH, a New Screener for Assessing Environmentally Sustainable and Healthy Diets

Proceedings

Ujué Fresán

Anna Boronat

Giannoula Mitsia

Maira Bes-Rastrollo

Itziar Zazpe

...

2023/11/14

Anandamide and 2-arachidonoylglycerol baseline plasma concentrations and their clinical correlate in gambling disorder

Fernando Fernández-Aranda

Mitona Pujadas

Bernat Mora-Maltas

Ignacio Lucas

Mónica Gómez-Peña

...

2023

PPARα/CB1 Receptor Dual Ligands as a Novel Therapy for Alcohol Use Disorder: Evaluation in Preclinical Rat Models

Alcohol

Fernando Rodríguez de Fonseca

Francisco Alen

Juan Decara

Victor Fernández-Echeverry

Gloria Brunori

...

2023/6/1

Y-chromosome in the olfactory neuroepithelium as a potential biomarker of depression in women with male offspring: an exploratory study

Molecular and Cellular Biochemistry

Pilar Álvarez

Beatriz Bellosillo

Francesc Colom

Raquel Longarón

Marta Barrera-Conde

...

2023/7/13

Psilocybin induces acute and persisting alterations in immune status in healthy volunteers: an experimental, placebo-controlled study

Brain, Behavior, and Immunity

NL Mason

A Szabo

KPC Kuypers

PA Mallaroni

R De La Torre Fornell

...

2023/11/1

Higher glucose parameters at baseline are related to hippocampal volume decline after a 2‐year multidomain lifestyle intervention to prevent cognitive decline in people at risk …

Alzheimer's & Dementia

Thais Lorenzo

Alina Solomon

Tiia Ngandu

Jenni Lehtisalo

Juan Domingo Gispert

...

2023/12

Instrument based on pictograms as a new tool for safety drug assessment in adults with intellectual disabilities

Neuroscience Applied

P Diaz-Pellicer

AM Aldea-Perona

M Pérez-Otero

B Fagundo

L Forcano

...

2023/1/1

PENSA study for the prevention of cognitive decline in APOE‐ɛ4 carriers with subjective cognitive decline: Description of baseline demographic and neuropsychological data of …

Alzheimer's & Dementia

Laura Forcano

Natalia Soldevila Domenech

Aida Cuenca

Thais Lorenzo

Anna Boronat

...

2023/6

State‐of‐the‐art therapy for Down syndrome

Nicola Lorenzon

Juanluis Musoles‐Lleó

Federica Turrisi

Maria Gomis‐González

Rafael De La Torre

...

2023/7

Exploring the influence of circulating endocannabinoids and nucleus accumbens functional connectivity on anorexia nervosa severity

Molecular Psychiatry

Romina Miranda-Olivos

Isabel Baenas

Trevor Steward

Roser Granero

Antoni Pastor

...

2023/9/28

An OMICS‐based analytical framework to identify metabolic predictors of the cognitive response to a multimodal intervention: preliminary findings from the PENSA Study

Alzheimer's & Dementia

Natalia Soldevila‐Domenech

Rin Wada

Anna Ruiz‐Colom

Federica Turrisi

Laura Forcano

...

2023/12

See List of Professors in Rafael de La Torre Fornell University(Universidad Pompeu Fabra)